TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters
<p>Abstract</p> <p>Background</p> <p>Exposure of cancer cells to chemotherapeutic agents may result in reduced sensitivity to structurally unrelated agents, a phenomenon known as multidrug resistance, MDR. The purpose of this study is to investigate cell growth inhibiti...
Main Authors: | Kirson Eilon D, Shmueli Esther, Schneiderman Rosa S, Palti Yoram |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/229 |
Similar Items
-
Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells
by: Moshe Giladi, et al.
Published: (2017-12-01) -
In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso
by: Roni Blatt, et al.
Published: (2021-06-01) -
176 Evaluating the safety of tumor treating fields (TTFields) application to the torso – in vivo studies
by: Shiri Davidi, et al.
Published: (2020-11-01) -
An Overview of Sub-Cellular Mechanisms Involved in the Action of TTFields
by: Jack A. Tuszynski, et al.
Published: (2016-11-01) -
Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Acting Dynamics
by: Tali Voloshin, et al.
Published: (2020-10-01)